Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) reported a stronger-than-expected sales performance in the third quarter, helped by a return to growth in developed markets. The FTSE 100-listed consumer health and hygiene company reported net revenues of £3.6 billion, a 7.0% rise on a like-for-like basis, supported by strong growth in its core products.
There's nothing like a sniffle season to remind investors of Reckitt Benckiser Group PLC's (LSE:RKT, ETR:3RB) place in the bathroom cabinet. The maker of Nurofen, Dettol and Durex is due to update the market on 22 October, and UBS reckons the numbers will show a business picking up pace after a sluggish start to the year.
Does Reckitt Benckiser Group PLC (RBGLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Reckitt Benckiser Group (RBGLY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does Reckitt Benckiser Group PLC (RBGLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does Reckitt Benckiser Group PLC (RBGLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) latest results have drawn a warm response from the City, with both UBS and Barclays highlighting strong momentum in the company's core business and a promising upgrade to full-year guidance. While overall like-for-like sales growth of 1.9% in the second quarter was only a touch ahead of expectations, the standout performance came from Core Reckitt, which delivered 5.3% organic growth, well ahead of what analysts had pencilled in.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) shares jumped 9% in early Thursday trading after the group upgraded its outlook for 2025, underpinned by a strong set of half-year results. The company now expects like-for-like (LFL) net revenue growth of between 3% and 4% for the year, and is targeting more than 4% growth for its core Reckitt business, signalling renewed confidence after a period of transformation.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has signed an agreement to divest its Essential Home business to Advent International for an enterprise value of up to US$4.8 billion. The deal also includes Reckitt retaining a 30% equity stake in the new entity, aligning with its strategy to become a more focused consumer health and hygiene company.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) second-quarter performance may not lag its consumer goods peers, but a material rerating of the stock still feels some way off, according to analysis by Citigroup. The American bank's London-based analysts, in a new note, say that second quarter results (due on Thursday 24 July) are likely to highlight strength in the firm's core emerging markets, notably China and India.
Britain's Reckitt is talking exclusively to private equity firm Advent International over a sale of the consumer goods group's Essential Home business, two sources with direct knowledge of the matter told Reuters.
Here is how Reckitt Benckiser Group PLC (RBGLY) and Reeds (REED) have performed compared to their sector so far this year.